Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals
1996

Effects of 5-fluorouracil microspheres on cancer in animals

Sample size: 119 publication Evidence: high

Author Information

Author(s): A Hagiwara, T Takahashi, K Sawai, C Sakakura, H Tsujimoto, T Imanishi, M Ohgaki, J Yamazaki, S Muranishi, A Yamamoto, T Fujita

Primary Institution: Kyoto Prefectural University of Medicine; Kyoto College of Pharmacy

Hypothesis

The new formulation of 5-fluorouracil (5FU) in microspheres will provide better therapeutic effects and lower toxicity compared to the aqueous solution.

Conclusion

The 5FU microspheres significantly improved drug distribution and reduced systemic toxicity while enhancing therapeutic effects in treating peritoneal carcinomatosis in animal models.

Supporting Evidence

  • 5FU-MS maintained higher concentrations of the drug in the target area for longer periods.
  • The toxicity of 5FU-MS was reduced to less than half that of the aqueous solution.
  • Survival times in mice treated with 5FU-MS were significantly longer than those treated with the aqueous solution.

Takeaway

Researchers created a new way to deliver a cancer drug that works better and is less harmful to the body than the old method.

Methodology

The study involved administering 5FU in microspheres to rats and mice, comparing drug distribution, toxicity, and therapeutic effects against an aqueous solution.

Limitations

The study was conducted in animal models, which may not fully represent human responses.

Participant Demographics

Male Wistar rats and BDF1 mice were used in the experiments.

Statistical Information

P-Value

p<0.05

Confidence Interval

95%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication